CIK 0001099800 · Large accelerated filer
Edwards Lifesciences Corp
Sign in to watch- Ticker
- EW
- Exchange
- NYSE
- Industry
- Orthopedic, Prosthetic & Surgical Appliances & Supplies
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 364316614
- Phone
- 9492502500
- Business address
- ONE EDWARDS WAY, IRVINE, CA, 92614
- Former names
- CVG CONTROLLED INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $10,886,105
- in 9 filings, $7.6M under 10b5-1 plans
Net −$10,886,105. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-05-07 | Markowitz Wayne CVP, JAPAC | Shares withheld for taxes | −264 | $83.20 | $22K | 22,498.87 |
| 2026-05-07 | Markowitz Wayne CVP, JAPAC | Grant or award · Employee Stock Option (Right to Acquire) | +26,400 | 26,400 | ||
| 2026-05-07 | Markowitz Wayne CVP, JAPAC | Grant or award · Performance Rights | +5,200 | 5,200 | ||
| 2026-05-07 | Zovighian Bernard J CEO | Grant or award | +43,800 | 124,057.65 | ||
| 2026-05-07 | Zovighian Bernard J CEO | Shares withheld for taxes | −4,153 | $83.20 | $346K | 119,904.65 |
| 2026-05-07 | Zovighian Bernard J CEO | Grant or award · Employee Stock Option (Right to Acquire) | +245,300 | 245,300 | ||
| 2026-05-07 | Zovighian Bernard J CEO | Grant or award · Performance Rights | +43,800 | 43,800 | ||
| 2026-05-07 | BOBO DONALD E JR CVP,Strategy/Corp Development | Grant or award | +7,850 | 28,647.25 | ||
| 2026-05-07 | BOBO DONALD E JR CVP,Strategy/Corp Development | Shares withheld for taxes | −831 | $83.20 | $69K | 27,816.25 |
| 2026-05-07 | BOBO DONALD E JR CVP,Strategy/Corp Development | Grant or award · Employee Stock Option (Right to Acquire) | +44,000 | 44,000 | ||
| 2026-05-07 | BOBO DONALD E JR CVP,Strategy/Corp Development | Grant or award · Performance Rights | +7,850 | 7,850 | ||
| 2026-05-07 | Ullem Scott B. CVP, Chief Financial Officer | Shares withheld for taxes | −1,373 | $83.20 | $114K | 39,575 |
| 2026-05-07 | Lippis Daniel J. CVP, TAVR | Grant or award | +7,850 | 41,531.91 | ||
| 2026-05-07 | Lippis Daniel J. CVP, TAVR | Shares withheld for taxes | −309 | $83.20 | $26K | 41,222.91 |
| 2026-05-07 | Lippis Daniel J. CVP, TAVR | Grant or award · Employee Stock Option (Right to Acquire) | +39,900 | 39,900 | ||
| 2026-05-07 | Lippis Daniel J. CVP, TAVR | Grant or award · Performance Rights | +7,850 | 7,850 | ||
| 2026-05-07 | Dahl Andrew M. SVP, Corporate Controller | Grant or award | +3,985 | 13,170.62 | ||
| 2026-05-07 | Dahl Andrew M. SVP, Corporate Controller | Grant or award | +3,020 | 16,190.62 | ||
| 2026-05-07 | Dahl Andrew M. SVP, Corporate Controller | Grant or award · Employee Stock Option (Right to Acquire) | +6,745 | 6,745 | ||
| 2026-05-07 | Chopra Daveen CVP, TMTT & Surgical | Grant or award | +9,675 | 41,594 |
Page 6 of 13 · 249 trades